Oasis Extracellular Matrix - Biochemically-interactive dressing

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Disponibbli minn:

William A Cook Australia Pty Ltd

Klassi:

Class III

Manifatturat minn:

Cook Biotech Incorporated 1425 Innovation Place, West Lafayette, Indiana, 47906 United States Of America

Żona terapewtika:

34083 - Biochemically-interactive dressing

Indikazzjonijiet terapewtiċi:

OASIS Extracellular Matrix is derived using a process that retains the natural composition of matrix molecules. It functions by binding to the receptors on the cells to activate cellular processes, such as replication and growth factor secretion. Oasis Extracellular Matrix is indicated for the management of wounds including: ? Partial and full-thickness wounds ? Pressure Ulcers ? Venous ulcers ? Chronic vascular ulcers ? Diabetic ulcers ? Second-degree burns ? Third-degree burns ? Trauma wounds (abrasions, lacerations, skin tears) ? Donor sites/grafts ? Draining wounds ? Surgical wounds (post-Mohs? surgery, post-laser surgery, podiatric, wound dehiscence)

L-istatus ta 'awtorizzazzjoni:

A

Data ta 'l-awtorizzazzjoni:

2018-03-08